While I don’t agree with this article completely (I personally think that mandated vaccines are a travesty not “important”) and that they ultimately do so much more harm than good, I wanted to show from a mainstream perspective (it is Forbes Magazine afterall) that someone has FINALLY stepped forward and peeled back the curtain to show that Merck has been deluding all of us. 

Millions of people who have autistic children are aware of how the MMR vaccine (measles, mumps, and rubella) is the most dangerous of all. Healthy children walk into a doctor’s office and damaged children, who will never be the same again, walk out. Parents are burdened with the grief of watching their dreams and the dreams of their children die with this one oh-so-horrible shot not to mention a lifetime of expenses that ensure in the hope that one day the child will heal. 

With this lawsuit, more and more people will see that Merck is truly an evil company out to corner a market and make billions off of you and your children. If there is any justice in the world, we can hope that at some point we will learn that Merck has also paid for government lobbyists who get laws past to require the vaccination of children who can’t speak up for themselves, and paid for media blackouts and propaganda that has kept people believing that these things are actually GOOD . If there is any justice these truths will come to light soon. In the meantime, it is a small victory that few will report I’m sure. 

by Gergana Koleva, Contributor

Anyone who falls on either side of the debate about vaccines’ alleged potential to cause harm is sure to have heard the big news this week — the unsealing of a whistleblower suit against Merck, filed back in 2010 by two former employees accusing the drugmaker of overstating the effectiveness of its mumps, measles, and rubella vaccine.

The scientists claim Merck defrauded the U.S. government by causing it to purchase an estimated four million doses of mislabeled and misbranded MMR vaccine per year for at least a decade, and helped ignite two recent mumps outbreaks that the allegedly ineffective vaccine was intended to prevent in the first place.

“As the single largest purchaser of childhood vaccines (accounting for more than 50 percent of all vaccine purchasers), the United States is by far the largest financial victim of Merck’s fraud. But the ultimate victims here are the millions of children who every year are being injected with a mumps vaccine that is not providing them with an adequate level of protection against mumps. And while this is a disease the CDC targeted to eradicate by now, the failure in Merck’s vaccine has allowed this disease to linger with significant outbreaks continuing to occur,” the suit alleges.
Researchers at Annual Science Fest Hail Universal Vaccines
Gergana Koleva
Contributor
Revised Recommendations for Vaccines Are Being Phased In, CDC Report Says
Gergana Koleva
Contributor

Vaccine Debate Acknowledged, Explained at Global Conference
Gergana Koleva
Contributor
It refers to a 2006 mumps outbreak in the Midwest, in which 6,500 cases were reported among a highly vaccinated population, and another in 2009, in which 5,000 cases were confirmed. By comparison, the annual average of mumps cases in the U.S. in the two decades preceding the 2006 outbreak was 265; before the introduction of the single-shot Mumpsvax vaccine in 1967, there were approximately 200,000 cases of the disease, according to the 55-page document.

If the accusations are true — thus far Merck has denied wrongdoing — the case would lend credence to the perception held by many that pharmaceutical companies are more interested in pursuing profits and preserving their market share than in protecting consumers’ health.

Specifically, the suit claims Merck manipulated the results of clinical trials beginning in the late 1990s so as to be able to report that the combined mumps vaccine, known as MMR-II (a revised version of the 1971 MMR shot containing a different strain of the rubella virus), is 95 percent effective, in an effort to maintain its exclusive license to manufacture it. This percentage is the benchmark used by the FDA to grant Merck approval to sell its original mumps vaccine in 1967. It is believed by vaccine authorities to guarantee herd immunity for people who have skipped on the shots.

However, instead of reformulating the vaccine whose declining efficacy Merck itself has acknowledged, the company reportedly launched a complicated scheme to adjust its testing technique so that it would yield the desired potency results. The virologists say they witnessed firsthand the fraud and were asked to directly participate in the dishonest testing, which was dubbed “Protocol 007″ and is outlined in great detail in the complaint.

While the Justice Department has refused to rule on the case after conducting its own two-year investigation, the allegations are crucial for a couple of reasons.

Without doubt, if true, they offer an extremely damaging view into the inner process of a company accused of misleading both regulators and consumers about a vital medical product. This is exactly the kind of profit-centered, patient-careless attitude many consumer advocates, vaccine opponents, and non-believers of all stripes ascribe to Big Pharma.

But the suit also serves to remind that vaccines are essential to preventing disease and that any drop in their efficacy is likely to result in disease resurgence and endanger the public’s health.

Unfortunately, what should be a clear distinction between scientific truth and a single alleged case of scientific misconduct is all too readily muddied by anti-vaccination advocates who conflate the two in order to advance their particular kind of dogma.

See the original article here….